ArticleJournal of clinical pharmacology2025

Exposure-Response Modeling and Simulation to Identify Optimal Mavacamten Posology When Coadministered with CYP3A4 and CYP2C19 Inhibitors in Patients with Obstructive HCM.

Samira Merali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.